Tyrosine kinase inhibitors

Details for Australian Patent Application No. 2001238575 (hide)

Owner Merck & Co., Inc.

Inventors Hungate, Randall W; Hartman, George D.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2001238575

PCT Pub. Number WO01/62251

Priority 60185023 25.02.00 US

Filing date 21 February 2001

Wipo publication date 3 September 2001

Acceptance publication date 7 April 2005

International Classifications

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

7 April 2005 Application Accepted

  Published as AU-B-2001238575

4 August 2005 Standard Patent Sealed

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001238576

2001238574